Subsequent mechanistic studies, based on the loss of BAX by RNA interference, and the gain or loss of miR-365, have proved the functional connection dominated by the miR-365-BAX axis in the cellular phenotype (including proliferation, migration, and invasiveness capabilities), which may provide potential targets for developing novel anti-cancer drugs and contribute to establishing new therapeutic regimes. The gene discussed is BAX; the disease is cancer.